DWTX stock

Dogwood Therapeutics, Inc. (DWTX) financials · $8.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Dogwood Therapeutics, Inc. (DWTX) $8.2M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$28.0M-$12.2M
Net Income-$34.3M-$12.3M
EPS (Diluted)-$7.13-$12.52
Cached annual balance sheet
LineFY2025FY2024
Total Assets$90.2M$94.3M
Current Assets$8.43M$16.5M
Cash & Equivalents$6.52M$14.8M
PP&E$12.8K$16.8K
Total Liabilities$15.3M$30.0M
Current Liabilities$3.06M$3.18M
Shareholders' Equity$74.9M-$10.1M
Retained Earnings-$108.1M-$73.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$15.6M-$8.79M
Investing Cash FlowN/A$3.76M
Financing Cash Flow$7.28M$16.7M
These statements as JSON? API free 100/day

FAQ

What is DWTX P/E and revenue?

Dogwood Therapeutics, Inc. (DWTX) $8.2M cap.

What is DWTX revenue?

DWTX income-statement cache has no revenue figure yet.

Is DWTX profitable?

Dogwood Therapeutics, Inc. last cached net income is -$34.3M (FY2025).

What are DWTX total assets?

Dogwood Therapeutics, Inc. last cached total assets are $90.2M (FY2025).

What is DWTX free cash flow?

No cached cash-flow row for DWTX yet.

Not investment advice. Cached statements, not a live tape.